Literature DB >> 34381271

Chemical and Physical Stability of an Admixture Containing Cefepime and Vancomycin in Lactated Ringer Solution.

Pegah Shakeraneh1, Risako Robinson1, Wesley D Kufel1,2,3, L Nathan Tumey2, Samantha R Benjamin2, Christopher D Miller1,3, William Darko1, Luke A Probst1,3, Robert W Seabury1,3.   

Abstract

Purpose: To evaluate the chemical and physical stability of an admixture containing cefepime and vancomycin in a single volume of lactated Ringer solution at refrigerated temperatures.
Methods: Cefepime 2000 mg and vancomycin 1000 mg were, respectively, reconstituted with 10 and 20 mL of sterile water for injection (SWFI) per manufacturer instructions. This resulted in cefepime and vancomycin concentrations of 200 and 50 mg/mL, respectively. The resulting cefepime and vancomycin solutions at 10 and 20 mL, respectively, were drawn up and injected into 1000 mL lactated Ringer solution. Aliquot samples were obtained on days 0 to 9, visually inspected for gross incompatibility, and then stored at -80°C. Samples were thawed on the day of the analysis and run through ultraperformance liquid chromatography. Area under the concentration-time curve (AUC) on each day was compared with baseline AUC values. Chemical stability was defined as an AUC more than 93% of the baseline value.
Results: No evidence of gross physical incompatibility was observed by visual inspection. Cefepime and vancomycin replicants were more than 94.5% and 98% of baseline AUC values. Therefore, all sample replicants were found to be more than 93% of their baseline AUC value.
Conclusion: An admixture containing cefepime 2000 mg and vancomycin 1000 mg in 1000 mL lactated Ringer solution appears to be chemically and physically stable at refrigerated temperatures for up to 9 days.
© The Author(s) 2020.

Entities:  

Keywords:  cefepime; chemical stability; drug stability; lactated Ringer; physical stability; vancomycin

Year:  2020        PMID: 34381271      PMCID: PMC8326845          DOI: 10.1177/0018578719901278

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  11 in total

1.  Incompatibility of ceftriaxone sodium with lactated Ringer's injection.

Authors:  J S Burkiewicz
Journal:  Am J Health Syst Pharm       Date:  1999-02-15       Impact factor: 2.637

2.  Stability of meropenem in intravenous solutions.

Authors:  P R Patel; S E Cook
Journal:  Am J Health Syst Pharm       Date:  1997-02-15       Impact factor: 2.637

3.  AJHP policy on manuscripts dealing with drug stability.

Authors:  C A Nichols; O H Welsh
Journal:  Am J Hosp Pharm       Date:  1988-07

4.  Survival Benefit and Cost Savings From Compliance With a Simplified 3-Hour Sepsis Bundle in a Series of Prospective, Multisite, Observational Cohorts.

Authors:  Daniel E Leisman; Martin E Doerfler; Mary Frances Ward; Kevin D Masick; Benjamin J Wie; Jeanie L Gribben; Eric Hamilton; Zachary Klein; Andrea R Bianculli; Meredith B Akerman; John K D'Angelo; Jason A D'Amore
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

5.  Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults.

Authors:  Nor'azim Mohd Yunos; Rinaldo Bellomo; Colin Hegarty; David Story; Lisa Ho; Michael Bailey
Journal:  JAMA       Date:  2012-10-17       Impact factor: 56.272

6.  Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.

Authors:  R Phillip Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven A Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Crit Care Med       Date:  2013-02       Impact factor: 7.598

7.  Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions.

Authors:  F P Bigley; R J Forsyth; M W Henley
Journal:  Am J Hosp Pharm       Date:  1986-11

8.  Impact of a Combination Antibiotic Bag on Compliance With Surviving Sepsis Campaign Goals in Emergency Department Patients With Severe Sepsis and Septic Shock.

Authors:  Michael P Lorenzo; Lindsay MacConaghy; Christopher D Miller; Gregory Meola; Luke A Probst; Brian Pratt; Jeff Steele; Robert W Seabury
Journal:  Ann Pharmacother       Date:  2017-10-27       Impact factor: 3.154

9.  Stability and compatibility of vancomycin for administration by continuous infusion.

Authors:  Violeta Raverdy; Els Ampe; Jean-Daniel Hecq; Paul M Tulkens
Journal:  J Antimicrob Chemother       Date:  2013-01-09       Impact factor: 5.790

10.  Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial.

Authors:  Ryan M Brown; Li Wang; Taylor D Coston; Nathan I Krishnan; Jonathan D Casey; Jonathan P Wanderer; Jesse M Ehrenfeld; Daniel W Byrne; Joanna L Stollings; Edward D Siew; Gordon R Bernard; Wesley H Self; Todd W Rice; Matthew W Semler
Journal:  Am J Respir Crit Care Med       Date:  2019-12-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.